TP53 and neoplasm: Robinson et al. recently reported that the mutation frequencies of AR, TP53, and PTEN were 62.7, 53.3, and 40.7%, respectively, in tumor biopsies from a cohort of 150 mCRPC affected individuals.43 The frequencies from the tumor seemed slightly higher than what we observed from the CTC samples.